Glenmark Pharmaceuticals Schedules Q1 FY2027 Earnings Call for Unaudited Results
Glenmark Pharmaceuticals Ltd has scheduled an Earnings Call regarding the company's Unaudited Financial Results for the quarter ended June 30, 2026 (Q1 FY2027). The call is set to take place on Monday, August 03, 2026.The event details allow stakeholders to access information concerning the first quarter of the financial year 2027.
Key Details of the Earnings Call
The earnings call will be held virtually as specified below:| Metric | Detail |
|---|---|
| Company | Glenmark Pharmaceuticals Ltd |
| Period Covered | Quarter ended June 30, 2026 (Q1 FY2027) |
| Date of Event | August 03, 2026 |
| Time | 8:30 am - 9:30 am IST |
Glenmark Pharmaceuticals provided multiple international and universal access numbers for participants to dial into the event. These include:
- Universal Access Number: +91 22 6280 1298, +91 22 7115 8199
- USA: 1 866 746 2133
- UK: 0 808 101 1573
- Singapore: 800 101 2045
- Hong Kong: 800 964 448
GLENMARK Stock Price Movement
Today, Glenmark Pharmaceuticals Limited settled in the green, edging up by 0.05% to close at ₹2240.6 today. The stock traded a volume of 260,175 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.